Literature DB >> 30307110

Renal manifestation of tuberous sclerosis complex.

John J Bissler1,2, J Christopher Kingswood3.   

Abstract

Tuberous sclerosis complex (TSC) is a tumor predisposition syndrome with significant renal cystic and solid tumor disease. It commonly causes several types of cystic disease and benign tumors (angiomyolipomata) in the kidneys that can both lead to significant premature loss of glomerular filtration rate. The main risks of angiomyolipomata, severe bleeding, loss of renal function, and pulmonary lymphangioleiomyomatosis, can be ameliorated by active surveillance and preemptive therapy with mTOR inhibitors. The cystogenic mechanism may involve primary cilia, but also appears to also involve a majority of normal tubular cells and may be driven by a minority of cells with mutations inactivating both their TSC1 or TSC2 genes. Malignant tumors are rare.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  angiomyolipoma; chronic; kidney disease; renal cystic disease; tuberous sclerosis complex

Mesh:

Substances:

Year:  2018        PMID: 30307110     DOI: 10.1002/ajmg.c.31654

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  13 in total

1.  Unexpected diagnosis in a child with hemolytic uremic syndrome: Answers.

Authors:  Eimear Kirby; Shiraz Elbashier; Clodagh Sweeney; Eilish Twomey; Kathleen Gorman; Michael Riordan; Atif Awan
Journal:  Pediatr Nephrol       Date:  2021-03-17       Impact factor: 3.714

2.  Blood pressure and glomerular filtration rate in youth with tuberous sclerosis complex.

Authors:  Efthymia Vargiami; Stella Stabouli; Christina Sidira; Maria Kyriazi; Athanasia Anastasiou; Athanasios Notopoulos; Dimitrios Zafeiriou
Journal:  Eur J Pediatr       Date:  2022-01-06       Impact factor: 3.183

3.  Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells.

Authors:  Xu Wang; Yang Zhao; Zhan Wang; Zhangcheng Liao; Yushi Zhang
Journal:  Cell Biochem Biophys       Date:  2022-10-01       Impact factor: 2.989

4.  Analysis of renal lesions in Chinese tuberous sclerosis complex patients with different types of TSC gene mutations.

Authors:  Wenda Wang; Yang Zhao; Xu Wang; Zhan Wang; Yi Cai; Hanzhong Li; Yushi Zhang
Journal:  Genet Mol Biol       Date:  2022-05-27       Impact factor: 2.087

5.  Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China.

Authors:  Xu Wang; Wenda Wang; Yang Zhao; Zhan Wang; Yushi Zhang
Journal:  Front Med (Lausanne)       Date:  2022-05-27

6.  Defining the Magnetic Resonance Features of Renal Lesions and Their Response to Everolimus in a Transgenic Mouse Model of Tuberous Sclerosis Complex.

Authors:  Shubhangi Agarwal; Emilie Decavel-Bueff; Yung-Hua Wang; Hecong Qin; Romelyn Delos Santos; Michael J Evans; Renuka Sriram
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

7.  Tuberous sclerosis complex exhibits a new renal cystogenic mechanism.

Authors:  John J Bissler; Fahad Zadjali; Dave Bridges; Aristotelis Astrinidis; Sharon Barone; Ying Yao; JeAnna R Redd; Brian J Siroky; Yanqing Wang; Joel T Finley; Michael E Rusiniak; Heinz Baumann; Kamyar Zahedi; Kenneth W Gross; Manoocher Soleimani
Journal:  Physiol Rep       Date:  2019-01

Review 8.  A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC).

Authors:  Johann Philipp Zöllner; David Neal Franz; Christoph Hertzberg; Rima Nabbout; Felix Rosenow; Matthias Sauter; Susanne Schubert-Bast; Adelheid Wiemer-Kruel; Adam Strzelczyk
Journal:  Orphanet J Rare Dis       Date:  2020-01-21       Impact factor: 4.123

9.  Tuberous Sclerosis Complex Axis Controls Renal Extracellular Vesicle Production and Protein Content.

Authors:  Fahad Zadjali; Prashant Kumar; Ying Yao; Daniel Johnson; Aristotelis Astrinidis; Peter Vogel; Kenneth W Gross; John J Bissler
Journal:  Int J Mol Sci       Date:  2020-03-03       Impact factor: 5.923

10.  Genetic identification of inherited cystic kidney diseases for implementing precision medicine: a study protocol for a 3-year prospective multicenter cohort study.

Authors:  Hayne Cho Park; Hyunjin Ryu; Yong-Chul Kim; Curie Ahn; Kyu-Beck Lee; Yeong Hoon Kim; Yunmi Kim; Seungyeup Han; Yaerim Kim; Eun Hui Bae; Seong Kwon Ma; Hee Gyung Kang; Yo Han Ahn; Eujin Park; Kyungjo Jeong; Jaewon Lee; Jungmin Choi; Kook-Hwan Oh; Yun Kyu Oh
Journal:  BMC Nephrol       Date:  2021-01-06       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.